Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2013

Open Access 01-12-2013 | Research article

Smoking cessation and the risk of cardiovascular disease outcomes predicted from established risk scores: Results of the Cardiovascular Risk Assessment among Smokers in Primary Care in Europe (CV-ASPIRE) Study

Authors: Pablo Mallaina, Christos Lionis, Hugo Rol, Renzo Imperiali, Andrew Burgess, Mark Nixon, Franco Mondello Malvestiti

Published in: BMC Public Health | Issue 1/2013

Login to get access

Abstract

Background

Smoking is a major risk factor for cardiovascular disease (CVD). This multicenter, cross-sectional survey was designed to estimate the cardiovascular (CV) risk attributable to smoking using risk assessment tools, to better understand patient behaviors and characteristics related to smoking, and characterize physician practice patterns.

Methods

1,439 smokers were recruited from Europe during 2011. Smokers were ≥40 years old, smoked > 10 cigarettes/day and had recent measurements on blood pressure and lipids. CV risk was calculated using the SCORE system, Framingham risk equations, and Progetto CUORE model. The CV risk attributable to smoking was evaluated using a simulated control (hypothetical non-smoker) with identical characteristics as the enrolled smoker. Risks assessed included CV mortality, coronary heart disease (CHD), CVD and hard CHD. Demographics, comorbidities, primary reasons for consultation, behavior towards previous attempts to quit, and interest in smoking cessation was assessed. Dependence on nicotine was evaluated using the Fagerström Test for Nicotine Dependence. GP practice patterns were assessed through a questionnaire.

Results

The prediction models consistently demonstrated a high CV risk attributable to smoking. For instance, the SCORE model demonstrated that this study population of smokers have a 100% increased probability of death due to cardiovascular disease in the next 10-years compared to non-smokers. A considerable amount of patients would like to hear from their GP about the different alternatives available to support their quitting attempt.

Conclusions

The findings of this study reinforce the importance of smoking as a significant predictor of long-term cardiovascular events. One of the best gains in health could be obtained by tackling the most important modifiable risk factors; these results suggest smoking is among the most important.
Literature
1.
2.
3.
Price JF, Mowbray PI, Lee AJ, Rumley A, Lowe GD, Fowkes FG: Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. Eur Heart J. 1999, 20: 344-53. 10.1053/euhj.1998.1194.CrossRefPubMed
4.
Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC): Guidelines for the Management of Arterial Hypertension. J Hypertens. 2007, 25: 87-1105. 10.1097/01.hjh.0000254375.73241.e2.CrossRef
5.
Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD): Guidelines on diabetes, pre-diabetes and cardiovascular disease: full text. Eur Heart J. 2007, 9: 1-74. 10.1016/j.ejheart.2006.12.005.CrossRef
6.
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L: INTERHEART Study Investigators: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet. 2004, 364: 937-952. 10.1016/S0140-6736(04)17018-9.CrossRefPubMed
7.
8.
Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation. 1998, 97 (18): 1837-47. 10.1161/01.CIR.97.18.1837.CrossRefPubMed
9.
D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB: General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008, 117: 743-53. 10.1161/CIRCULATIONAHA.107.699579.CrossRefPubMed
10.
D'Agostino RB, Grundy S, Sullivan LM, Wilson P: Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001, 286 (2): 180-187. 10.1001/jama.286.2.180.CrossRefPubMed
11.
Murabito JM, D'Agostino RB, Silbershatz H, Wilson WF: Intermittent claudication. A risk profile from the Framingham Heart Study. Circulation. 1997, 96 (1): 44-9. 10.1161/01.CIR.96.1.44.CrossRefPubMed
12.
D'Agostino RB, Russell MW, Huse DM, Ellison RC, Silbershatz H, Wilson PW, Hartz SC: Primary and subsequent coronary risk appraisal: new results from the Framingham Study. Am Heart J. 2000, 139 (2 Pt 1): 272-281.CrossRefPubMed
13.
Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM: SCORE project group: Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003, 24 (11): 987-1003. 10.1016/S0195-668X(03)00114-3.CrossRefPubMed
14.
Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Scholte Op Reimer WJM, Vrints C, Wood D, Luis Zamorano J, Zannad F: European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J. 2012, 33: 1635-1701.CrossRefPubMed
15.
Palmieri L, Panico S, Vanuzzo D, Ferrario M, Pilotto L, Sega R, Cesana G, Giampaoli S, per il Gruppo di Ricerca del Progetto CUORE: La valutazione del rischio cardiovascolare globale assoluto: il punteggio individuale del Progetto CUORE. Ann 1st Super Sanita. 2004, 40 (4): 393-399.
16.
Sadowski J, Ruffieux C, Cornuz J: Self-reported smoking cessation activities among Swiss primary care physicians. BMC Fam Pract. 2009, 10: 22-10.1186/1471-2296-10-22.CrossRef
17.
18.
McEwen A, West R, Owen L, Raw M: General practitioners’ views on and referral to NHS smoking cessation services. Public Health. 2005, 119 (4): 262-268. 10.1016/j.puhe.2004.05.016.CrossRefPubMed
19.
O’Sullivan J: An evaluation of general practitioners’ interactions with the smoking cessation service and the impact of a desktop resource on the service. MA thesis. 2006, Cork: University College Cork Department of Epidemiology and Public Health. National University of Ireland
20.
Dekker HM, Looman CWN, Adriaanse HP, van der Maas PJ: Prevalence of smoking in physicians and medical students, and the generation effect in The Netherlands. Soc Sci Med. 1993, 36 (6): 817-822. 10.1016/0277-9536(93)90042-3.CrossRefPubMed
21.
Stead M, Angus K, Holme I, Cohen D, Tait G: PESCE European Research Team: Factors influencing European GPs’ engagement in smoking cessation: a multi-country literature review. Br J GenPract. 2009, 59 (566): 682-690.
22.
Prignot J, Bartsch P, Vermeire P, Jamart J, Wanlin M, Uydebrouck M, Thijs J: Physician’s involvement in the smoking cessation process of their patients. Results of a 1998 survey among 4,643 Belgian physicians. Acta Clinica Belgica. 2000, 55 (5): 266-275.PubMed
23.
Lennox AS, Taylor R: Smoking cessation activity within primary health care in Scotland: present constraints and their implications. Health Education Journal. 1995, 54 (1): 48-60. 10.1177/001789699505400106.CrossRef
24.
Brotons C, Björkelund C, Bulc M, Ciurana R, Godycki-Cwirko M, Jurgova E, Kloppe P, Lionis C, Mierzecki A, Piñeiro R, Pullerits L, Sammut MR, Sheehan M, Tataradze R, Thireos EA, Vuchak J: EUROPREV network: Prevention and health promotion in clinical practice: the views of general practitioners in Europe. Prev Med. 2005, 40: 595-601. 10.1016/j.ypmed.2004.07.020.CrossRefPubMed
25.
Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO: The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991 Sep, 86 (9): 1119-1127. 10.1111/j.1360-0443.1991.tb01879.x.CrossRefPubMed
26.
Kotsoni C, Antonakis N, Markaki A, Lionis C: Do patients with chronic obstructive pulmonary disease receive smoking cessation advice and interventions in rural Crete? Report from a medical audit study. Aust J Rural Health. 2008 Dec, 16 (6): 385-6. 10.1111/j.1440-1584.2008.01024.x.CrossRefPubMed
27.
Global initiative for chronic obstructive lung disease (GOLD): Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (Revised 2011).
28.
Antonakis N, Xylouri I, Alexandrakis M, Cavoura C, Lionis C: Seeking prescribing patterns in rural Crete: a pharmacoepidemiological study from a primary care area. Rural and Remote Health. 2006, 6: 488-PubMed
29.
Tonstad S, Johnston A: Cardiovascular risks associated with smoking: a review for clinicians. Eur J Cardiovasc Prev Rehabil. 2006 Aug, 13 (4): 507-14. 10.1097/01.hjr.0000214609.06738.62.CrossRefPubMed
30.
Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L: INTERHEART Study Investigators: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. The Lancet. 2004, 364 (9438): 937-952. 10.1016/S0140-6736(04)17018-9.CrossRef
31.
32.
Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, Dorfman SF, Froelicher ES, Goldstein MG, Healton CG, Henderson PN, Heyman RB, Koh HK, Kottke TE, Lando HA, Mecklenburg RE, Mermelstein RJ, Mullen PD, Orleans CT, Robinson L, Stitzer ML, Tommasello AC, Villejo L, Wewers ME: Treating Tobacco Use and Dependence, Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service. 2008
Metadata
Title
Smoking cessation and the risk of cardiovascular disease outcomes predicted from established risk scores: Results of the Cardiovascular Risk Assessment among Smokers in Primary Care in Europe (CV-ASPIRE) Study
Authors
Pablo Mallaina
Christos Lionis
Hugo Rol
Renzo Imperiali
Andrew Burgess
Mark Nixon
Franco Mondello Malvestiti
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2013
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-13-362

Other articles of this Issue 1/2013

BMC Public Health 1/2013 Go to the issue

Research article

Illness, medical expenditure and household consumption: observations from Taiwan

Research article

Application of the COOP/WONCA charts to aged patients with chronic obstructive pulmonary disease: a comparison between Japanese and Chinese populations

Study protocol

A randomized control trial: training program of university students as health promoters

Research article

Gender differences in exposure to SRH information and risky sexual debut among poor Myanmar youths

Research article

pH1N1 - a comparative analysis of public health responses in Ontario to the influenza outbreak, public health and primary care: lessons learned and policy suggestions

Research article

Perceived neighborhood problems: multilevel analysis to evaluate psychometric properties in a Southern adult Brazilian population